121 related articles for article (PubMed ID: 3083762)
1. Striatal dopamine depletion, dopamine receptor stimulation, and GABA metabolism: implications for the therapy of Parkinson's disease.
Bennett JP
Ann Neurol; 1986 Feb; 19(2):194-7. PubMed ID: 3083762
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
Calabresi P; Mercuri NB; Sancesario G; Bernardi G
Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
[TBL] [Abstract][Full Text] [Related]
3. Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss.
Kish SJ; Rajput A; Gilbert J; Rozdilsky B; Chang LJ; Shannak K; Hornykiewicz O
Ann Neurol; 1986 Jul; 20(1):26-31. PubMed ID: 2874765
[TBL] [Abstract][Full Text] [Related]
4. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
Strömberg I; Kehr J; Andbjer B; Fuxe K
Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
[TBL] [Abstract][Full Text] [Related]
5. GABA-mimetic drugs enhance apomorphine-induced contralateral turning in rats with unilateral nigrostriatal dopamine denervation: implications for the therapy of Parkinson's disease.
Bennett JP; Ferrari MB; Cruz CJ
Ann Neurol; 1987 Jan; 21(1):41-5. PubMed ID: 3827213
[TBL] [Abstract][Full Text] [Related]
6. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
Bennett JP; Wooten GF
Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
[TBL] [Abstract][Full Text] [Related]
7. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants.
Winkler C; Bentlage C; Nikkhah G; Samii M; Björklund A
Exp Neurol; 1999 Feb; 155(2):165-86. PubMed ID: 10072293
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
[TBL] [Abstract][Full Text] [Related]
9. Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism.
Richard MG; Bennett JP
Exp Neurol; 1994 Sep; 129(1):57-63. PubMed ID: 7925842
[TBL] [Abstract][Full Text] [Related]
10. Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model.
Melamed E; Hefti F; Wurtman RJ
Isr J Med Sci; 1982 Jan; 18(1):159-63. PubMed ID: 6121770
[TBL] [Abstract][Full Text] [Related]
11. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease.
Dunah AW; Wang Y; Yasuda RP; Kameyama K; Huganir RL; Wolfe BB; Standaert DG
Mol Pharmacol; 2000 Feb; 57(2):342-52. PubMed ID: 10648644
[TBL] [Abstract][Full Text] [Related]
12. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
Zharkovskiĭ AM; Nurk AM
Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic regulation of the GABAergic transmission in the rat basal ganglia.
Di Cara B; Samuel D; Salin P; Kerkerian-Le Goff L; Daszuta A
Synapse; 2003 Nov; 50(2):144-50. PubMed ID: 12923817
[TBL] [Abstract][Full Text] [Related]
14. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F
J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356
[TBL] [Abstract][Full Text] [Related]
15. The expression of the calcium binding protein calretinin in the rat striatum: effects of dopamine depletion and L-DOPA treatment.
Mura A; Feldon J; Mintz M
Exp Neurol; 2000 Aug; 164(2):322-32. PubMed ID: 10915571
[TBL] [Abstract][Full Text] [Related]
16. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
[TBL] [Abstract][Full Text] [Related]
17. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
Lavoute C; Weiss M; Rostain JC
Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
[TBL] [Abstract][Full Text] [Related]
18. Continuous and intermittent levodopa differentially affect basal ganglia function.
Juncos JL; Engber TM; Raisman R; Susel Z; Thibaut F; Ploska A; Agid Y; Chase TN
Ann Neurol; 1989 May; 25(5):473-8. PubMed ID: 2774488
[TBL] [Abstract][Full Text] [Related]
19. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
Zeevalk GD; Manzino L; Sonsalla PK
Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
[TBL] [Abstract][Full Text] [Related]
20. Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats.
Meshul CK; Kamel D; Moore C; Kay TS; Krentz L
Exp Neurol; 2002 May; 175(1):257-74. PubMed ID: 12009777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
